ClinicalTrials.gg
CompletedNCT04274621Updated Mar 3, 2020

The Application Value of Non-contact Infrared Thermometers in Temperature Screening in the General Population

An observational study in Non-contact Infrared Thermometer; Rapid Screening, sponsored by Ningbo No. 1 Hospital. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-03.

Sponsored by Ningbo No. 1 Hospital · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
572
Ages
18 Years and older
Sex
All
01

Study summary

The first epidemic of 2019 novel coronavirus (2019-nCoV)-infected pneumonia(NCIP) in Wuhan, China, has attracted global attention because of its strong transmission ability and certain fatality. Analyzing the clinical data of hospitalized patients with 2019-nCoV infection, the current studies found that fever, fatigue and dry cough were common symptoms, and 43.8% of the patients showed fever before admission. Some scholars emphasize that the most effective means to control the outbreak are early detection, early isolation, early diagnosis and early treatment. In the face of the pressure that a large number of people need rapid screening and the deficiency that the forehead temperature measurement is easily affected by the environment, the investigators would like to explore the accuracy and advantages of wrist temperature measurement in different environments and conditions in this period. And determine the thresholds of non-contact infrared thermometer for the screening of patients with fever, in order to provide clinical indicators for further detection of patients with suspected fever.

02

Conditions studied

  • Non-contact Infrared Thermometer; Rapid Screening
03

In context

Lead sponsor

Ningbo No. 1 Hospital is the lead sponsor of 59 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients, family members of patients, and medical staff

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients, family members of patients, and medical staff

Exclusion criteria

Exclusion Criteria:

  • age \<= 18 years
  • Wearing hearing aid, having a cerumen
  • Soft tissue infection, trauma patients
  • Missing data
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
572 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients, family members of patient, medical staff
06

What researchers measure

Primary outcomes

  1. The Comparison of accuracy between wrist temperature and forehead temperature.

    The investigators used non-contact infrared thermometers to measure the value of wrist and forehead temperature in patients, family members of patients, medical staff. They record the value of temperature in the population and environment temperature.

    Time frame: cross-sectional analyses in 2020

07

Study locations

1 site
  • Ningbo first hospital
    Ningbo, Zhejiang 315010, China
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2020 to primary completion in Feb 2020, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 14, 2020
First posted
Feb 18, 2020
StartActual
Feb 14, 2020
Primary completionActual
Feb 17, 2020
CompletionActual
Feb 20, 2020
Last update
Mar 3, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 3, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04274621
Lead sponsor
Ningbo No. 1 Hospital
Responsible party
Sponsor
First posted
Feb 18, 2020
Start date
Feb 14, 2020
Primary completion
Feb 17, 2020
Completion
Feb 20, 2020
Last update
Mar 3, 2020

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion